Literature DB >> 23983854

The secret "spice": an undetectable toxic cause of seizure.

Adam de Havenon1, Brian Chin, Karen C Thomas, Pegah Afra.   

Abstract

Neurologists and emergency department physicians are frequently involved in the comprehensive evaluation of a first generalized seizure. An important aspect of this evaluation is a detailed history which can identify a provoked seizure secondary to drug toxicity and hence avoid unnecessary treatment with antiepileptic drugs. "Spice" is an umbrella term for a variety of synthetic cannabinoid products whose inhalation has been associated with an increasing number of toxic side effects resulting in emergency department visits. These side effects (including psychosis, tachyarrhythmia, and seizures) are not typically seen with marijuana (Cannabis sativa) use. We report 2 patients with no prior history of neurological disease that experienced their first generalized tonic-clonic seizure after smoking Spice. The mechanism behind the possible proconvulsant effect of synthetic cannabinoids is not known, but it may be due to their effects at the cannabinoid receptor CB1. Although the US Drug Enforcement Administration placed 5 synthetic cannabinoids into schedule 1 for a 12-month period beginning March 2011, new Spice products containing different synthetic cannabinoids continue to emerge. Because synthetic cannabinoids are not detectable on commercial drug screens it is important that neurologists and emergency department physicians consider Spice inhalation in their differential diagnosis of a first generalized seizure.

Entities:  

Keywords:  Spice; cannabis toxicity; first generalized seizure; marijuana toxicity; provoked seizure; synthetic cannabinoid; toxic seizure

Year:  2011        PMID: 23983854      PMCID: PMC3726077          DOI: 10.1177/1941874411417977

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  13 in total

1.  Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.

Authors:  N Hájos; C Ledent; T F Freund
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Coordination Active du Réseau Observatoire Longitudinal de l' Epilepsie.

Authors:  P Jallon; P Loiseau; J Loiseau
Journal:  Epilepsia       Date:  2001-04       Impact factor: 5.864

3.  The emergence and analysis of synthetic cannabinoids.

Authors:  Simon Hudson; John Ramsey
Journal:  Drug Test Anal       Date:  2011-02-21       Impact factor: 3.345

4.  Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples.

Authors:  Sebastian Dresen; Stefan Kneisel; Wolfgang Weinmann; Ralf Zimmermann; Volker Auwärter
Journal:  J Mass Spectrom       Date:  2011-01-24       Impact factor: 1.982

5.  Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.

Authors:  M J Wallace; J L Wiley; B R Martin; R J DeLorenzo
Journal:  Eur J Pharmacol       Date:  2001-09-28       Impact factor: 4.432

6.  Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.

Authors:  Nicholas A Jones; Andrew J Hill; Imogen Smith; Sarah A Bevan; Claire M Williams; Benjamin J Whalley; Gary J Stephens
Journal:  J Pharmacol Exp Ther       Date:  2009-11-11       Impact factor: 4.030

Review 7.  An introduction to the endocannabinoid system: from the early to the latest concepts.

Authors:  Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-02       Impact factor: 4.690

8.  Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure.

Authors:  Dale C Hesdorffer; Emma K T Benn; Gregory D Cascino; W Allen Hauser
Journal:  Epilepsia       Date:  2009-01-26       Impact factor: 5.864

Review 9.  First seizure definitions and worldwide incidence and mortality.

Authors:  W Allen Hauser; Ettore Beghi
Journal:  Epilepsia       Date:  2008       Impact factor: 5.864

Review 10.  Marijuana: an effective antiepileptic treatment in partial epilepsy? A case report and review of the literature.

Authors:  Katherine Mortati; Barbara Dworetzky; Orrin Devinsky
Journal:  Rev Neurol Dis       Date:  2007
View more
  14 in total

1.  Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine.

Authors:  Mark J Burish; Katie L Thoren; Maura Madou; Shahed Toossi; Maulik Shah
Journal:  Neurohospitalist       Date:  2015-01

Review 2.  Synthetic Pot: Not Your Grandfather's Marijuana.

Authors:  Benjamin M Ford; Sherrica Tai; William E Fantegrossi; Paul L Prather
Journal:  Trends Pharmacol Sci       Date:  2017-02-02       Impact factor: 14.819

3.  Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study.

Authors:  Eef L Theunissen; Nadia R P W Hutten; Natasha L Mason; Stefan W Toennes; Kim P C Kuypers; Eliza B de Sousa Fernandes Perna; Johannes G Ramaekers
Journal:  Br J Pharmacol       Date:  2017-11-29       Impact factor: 8.739

4.  The New Classes of Synthetic Illicit Drugs Can Significantly Harm the Brain: A Neuro Imaging Perspective with Full Review of MRI Findings.

Authors:  S Creagh; D Warden; M A Latif; A Paydar
Journal:  Clin Radiol Imaging J       Date:  2018-04-25

5.  Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports.

Authors:  Michal Ordak; Aleksandra Zmysłowska; Miłosz Bielski; Daniel Rybak; Maja Tomaszewska; Katarzyna Wyszomierska; Aleksandra Kmiec; Natalia Garlicka; Maria Zalewska; Michal Zalewski; Tadeusz Nasierowski; Elzbieta Muszynska; Magdalena Bujalska-Zadrozny
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

6.  Chronic Synthetic Marijuana Use: A Case of First-Onset Seizures as a Withdrawal Symptom.

Authors:  Amber N Edinoff; Prithvi Doppalapudi; Juliana M Fort
Journal:  Health Psychol Res       Date:  2022-04-26

7.  Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice.

Authors:  Catheryn D Wilson; Fang Zheng; William E Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2022-08-06       Impact factor: 4.415

Review 8.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 9.  Emerging drugs of abuse: current perspectives on synthetic cannabinoids.

Authors:  Danièle Debruyne; Reynald Le Boisselier
Journal:  Subst Abuse Rehabil       Date:  2015-10-20

Review 10.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.